{"transactions":[{"id":802673,"issuer":{"id":8195,"kind":"organization","name":"Acurx Pharmaceuticals, Inc."},"owners":[{"id":51618,"kind":"person","name":"DEAN JACK H","position":1,"cik":"0001434978","reported_name":"DEAN JACK H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-04-22T16:20:39.000Z","date":"2026-04-20","kind":"grant","planned":false,"acquired":true,"shares":2150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This stock option award is related to service on the Issuer's board of directors granted pursuant to the Issuer's Director Compensation Policy. The shares subject to the options shall vest on April 20, 2027."}],"balance_after":2150,"derivative":{"exercise_price":2.36,"exercise_date":"2027-04-20","expiration_date":"2036-04-20","underlying":"Common Stock","underlying_shares":2150},"source":{"system":"sec-edgar","filing":"0001104659-26-046844","document":"tm2612397-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434978/000110465926046844/tm2612397-7_4seq1.xml","form_type":"4"}},{"id":1306498,"issuer":{"id":8195,"kind":"organization","name":"Acurx Pharmaceuticals, Inc."},"owners":[{"id":51618,"kind":"person","name":"DEAN JACK H","position":1,"cik":"0001434978","reported_name":"DEAN JACK H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants for Common Stock","published_at":"2025-01-08T16:30:11.000Z","date":"2025-01-06","kind":"purchase","planned":false,"acquired":true,"shares":9852,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Acquired in a concurrent private placement of warrants by Acurx Pharmaceuticals, Inc. in connection with the registered direct offering of common stock."}],"balance_after":9852,"derivative":{"exercise_price":0.9,"exercise_date":"2025-01-07","expiration_date":"2030-01-07","underlying":"Common Stock","underlying_shares":9852},"source":{"system":"sec-edgar","filing":"0001104659-25-002046","document":"tm252665-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434978/000110465925002046/tm252665-1_4seq1.xml","form_type":"4"}},{"id":1306497,"issuer":{"id":8195,"kind":"organization","name":"Acurx Pharmaceuticals, Inc."},"owners":[{"id":51618,"kind":"person","name":"DEAN JACK H","position":1,"cik":"0001434978","reported_name":"DEAN JACK H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-08T16:30:11.000Z","date":"2025-01-06","kind":"purchase","planned":false,"acquired":true,"shares":9852,"price":1.015,"value":9999.78,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired at the offering price in a registered direct offering of common stock by Acurx Pharmaceuticals, Inc."}],"balance_after":21776,"source":{"system":"sec-edgar","filing":"0001104659-25-002046","document":"tm252665-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434978/000110465925002046/tm252665-1_4seq1.xml","form_type":"4"}},{"id":1475087,"issuer":{"id":8195,"kind":"organization","name":"Acurx Pharmaceuticals, Inc."},"owners":[{"id":51618,"kind":"person","name":"DEAN JACK H","position":1,"cik":"0001434978","reported_name":"DEAN JACK H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2024-06-18T16:10:16.000Z","date":"2024-06-17","kind":"grant","planned":false,"acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option award is related to service on the Issuer's board of directors granted pursuant to the Issuer's Director Compensation Policy. The shares subject to the options shall vest on June 17, 2025."}],"balance_after":12000,"derivative":{"exercise_price":2.38,"expiration_date":"2034-06-17","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001104659-24-072806","document":"tm2417510-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434978/000110465924072806/tm2417510-1_4seq1.xml","form_type":"4"}},{"id":1851946,"issuer":{"id":8195,"kind":"organization","name":"Acurx Pharmaceuticals, Inc."},"owners":[{"id":51618,"kind":"person","name":"DEAN JACK H","position":1,"cik":"0001434978","reported_name":"DEAN JACK H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2023-06-16T17:45:50.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option award is related to service on the Issuer's board of directors granted pursuant to the Issuer's Director Compensation Policy. The shares subject to the options shall vest on June 15, 2024."}],"balance_after":10000,"derivative":{"exercise_price":2.75,"expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-23-072370","document":"tm2319012-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434978/000110465923072370/tm2319012-3_4seq1.xml","form_type":"4"}},{"id":2641030,"issuer":{"id":8195,"kind":"organization","name":"Acurx Pharmaceuticals, Inc."},"owners":[{"id":51618,"kind":"person","name":"DEAN JACK H","position":1,"cik":"0001434978","reported_name":"DEAN JACK H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2021-07-06T16:11:21.000Z","date":"2021-07-01","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option award is related to service on the Issuer's board of directors granted pursuant to the Issuer's Director Compensation Policy. 1/36th of the shares granted shall become vested and exercisable as of each monthly anniversary from July 1, 2021, such that all shares subject to this stock option shall be fully vested and exercisable by July 1, 2024."}],"balance_after":50000,"derivative":{"exercise_price":6.18,"expiration_date":"2031-06-30","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001104659-21-089405","document":"tm2121302d1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434978/000110465921089405/tm2121302d1_4seq1.xml","form_type":"4"}},{"id":4348628,"issuer":{"id":129056,"kind":"organization","name":"PLx Pharma Inc.","symbol":"PLXP"},"owners":[{"id":51618,"kind":"person","name":"DEAN JACK H","position":1,"cik":"0001434978","reported_name":"DEAN JACK H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options","published_at":"2017-04-20T06:22:33.000Z","date":"2017-01-17","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to purchase shares of common stock vest as follows: options to purchase 10,000 shares of common stock vested on January 17, 2017; options to purchase 416 shares of common stock vest monthly in each of the 23 months after the date of grant and options to purchase 432 shares of common stock will vest on the 24th month anniversary of the date of grant."}],"balance_after":20000,"derivative":{"exercise_price":1.8,"expiration_date":"2027-01-17","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001144204-17-021124","document":"v464465_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497504/000114420417021124/v464465_4.xml","form_type":"4"}}]}